PRMT7 and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, targeting serine-glycine regulatory enzyme, PRMT7, reprogrammed glycine metabolism, which led to excessive levels of the toxin methylglyoxal and ultimately reduction in the number of CML LSCs.66